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Background
Subcutaneous allergen-specific immunotherapy is bur-
dened with the risk of severe systemic reactions; therefore,
sublingual administration route has been increasingly
investigated worldwide. The goal was to assess the thera-
peutic effect and safety of allergen therapeutic vaccines of
Dermatophagoides pteronyssinus, Dermatophagoides sibo-
ney and Blomia tropicalis House-Dust mites (VALERGEN,
BIOCEN, Cuba) by sublingual route, in asthmatic patients.
Methods
Three Double-Blind Placebo-Controlled clinical trials were
performed in 40 patients each, showing asthmatic symp-
toms and positive predominant Skin Prick Test (SPT) to
each mite, respectively. Half of subjects were randomized
to placebo. Patients received the treatment consisting on
sublingual drops with increasing daily doses for 3 weeks
and maintenance doses (2000 BU) twice a week until
12 moths. Therapeutic effect was assessed after 6 and
12 months using symptoms/medication diary cards, peak
expiratory flow (PEF) measures and skin sensitivity to
investigated mites. Adverse reactions were classified using
the World Allergy Organization scale.
Results
The treatment reduced significantly (p<0.01) clinical
symptoms (38%, CI95%: 33-44) and medication intake
(26%, CI95%:21-32) with respect to placebo. The skin
sensitivity to the allergens decreased also significantly
(p<0.01). The allergen amount needed to induce a posi-
tive SPT increased 52-fold. PEF variability decreased
also significantly (p<0.05). The treatment was considered
effective in 77% of patients. A major advantage as com-
pared to subcutaneous route was a remarked lower fre-
quency of adverse effects. Local reactions were noted
only in 0.43% of administrations. No systemic reactions
were observed.
Conclusions
Summarizing sublingual immunotherapy using VALER-
GEN vaccines is effective and safe in mite-sensitive asth-
matic patients.
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